Chiesi Group Competitors and Similar CompaniesClear all

Chiesi Group's competitors and similar companies include EMS Pharma, CSL Behring, Vertex Pharmaceuticals and Cipla.

	Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.	CSL Behring CSL Behring is a provider of life-saving medicines.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 1935	Founding Date 1964	Founding Date 1904	Founding Date 1989	Founding Date 1935
Type	Type Subsidiary	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more	Locations BR HQ	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees 5,8541% increase	Employees 12,7441% increase	Employees 7,5692% decrease	Employees 5,40013% increase	Employees 27,764
Financial
Revenue (est.)	Revenue (est.) €2.4b (Y, 2021)	Revenue (est.) N/A	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) $12b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $4.5b (FY, 2020)	Gross profit $10.4b (FY, 2025)	Gross profit ₹195b (FY, 2026)
Operating ⚠
Manufacturing Sites	Manufacturing Sites 3 (Y, 2021)	Manufacturing Sites N/A	Manufacturing Sites N/A	Manufacturing Sites N/A	Manufacturing Sites 46 (FY, 2024)
Products	Products N/A	Products N/A	Products N/A	Products 6 (FY, 2022)	Products 1.5 k (FY, 2024)